Upadacitinib for Alopecia: Current Evidence and Clinical Insights

By afschroeder • August 7, 2025

Stirrat T, Thakker S, Bejugam D, Goh C, Lipner SR. Upadacitinib for Alopecia: Current Evidence and Clinical Insights. Skin Appendage Disord. 2025 Aug;11(4):320-334. doi: 10.1159/000544868. Epub 2025 Feb 25. PMID: 40771447; PMCID: PMC12324716.

Tags: alopecia areata, Dermatology, hair loss, Janus kinase 1 inhibitors, Publications, scoping review, Upadacitinib

Benefits of Earlier Apremilast Initiation in Patients with Psoriasis and Limited Skin Involvement: Results from a Real-World Retrospective Study

Armstrong A, Strober B, Gisondi P, Orroth KK, Cordey M, Kent ST, Deignan C, Jardon S, Hernandez RK, Brookhart MA, Stein Gold L. Benefits of[...]

Hot Topics: Exploring Artificial Intelligence and Inflammatory Memory in the Management of Psoriatic Diseases

Shucheng H, Armstrong AW, Eidsmo L, Poddubnyy D. Hot Topics: Exploring Artificial Intelligence and Inflammatory Memory in the Management of Psoriatic Diseases. J Rheumatol. 2025[...]

Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual Meeting

Romanelli S, Childs B, Strand V, Armstrong AW, Perez-Chada LM, Merola JF, Gottlieb AB. Report of the IDEOM Meeting Adjacent to the GRAPPA 2024 Annual[...]